Scientists at NYU’s Center for Genomics & Systems Biology have created a 3D model that could advance cancer screening and ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Median overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...

Learn about the holistic approach to metastatic breast cancer treatment that prioritises quality of life alongside effective ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened last month.

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...

Neal Shore, MD, FACS, discussed a study on survival outcomes in metastatic castration-sensitive prostate cancer comparing ...

Cardiff has a cash runway of 5-6 quarters, but will need additional funding, potentially leading to significant shareholder ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...